Abstract 790: Cellular decomposition and metabolic profiling of the tumor microenvironment tumor-stroma interface using high-dimensional spatial proteomics and image analytics.

Abstract Introduction There is an urgent need for the development of better prognostic and predictive biomarkers for cancer immunotherapy across a number of solid cancers. Here we sought to characterise the tumour microevironment (TME) using high-dimensional spatial proteomics paired with advance image analytics to define tumour, stomal and interface regions. We developed custom functional and metabolic content to profile these interface regions to determine activity across transitional zones. Methods Using high dimensional spatial proteomic profiling (Phenocycler Fusion, Quanterix) with a custom immuno-metabolic panel targeting over 68 proteins, including markers for tumor, stroma, structural components, immune cell types, functional states, and metabolic activity, we characterized cell types, sub-types and metabolic activity across the tumor-stromal interface regions. Custom image analytics, utilizing Visiopharm’s analytic pipeline and workflow, enabled precise identification and mapping of spatially distinct tumor and stromal interface regions associated with TME composition. Characterization of cellularity and metabolic activity was further performed through the Phenoplex™ guided workflow. Results We found intra-tumor and intra-stromal regions were distinct from tumor-interface and stromal-interface regions in terms of TME composition and metabolic activity. Moreover, whilst cell proportions alone were not predictive of clinical benefit, the nuances were in the tumor and immune cell sub-types which were functionally and metabolically characterized. We found a tumor metabolic signature predictive of poorer clinical outcomes and reciprocally high metabolic activity in immune cells at the TME interface associated with benefit from immunotherapy. Conclusion Taken together, this study highlights the value of high-dimensional spatial proteomics covering functional and metabolic profiling of the TME and the advanced image analytics providing insights into the TME. Citation Format: Arutha Kulasinghe, Felicia Roland, Michelle Poulin, Ritu Mihani, Katherine Hales, Daniel Winkowski. Cellular decomposition and metabolic profiling of the tumor microenvironment tumor-stroma interface using high-dimensional spatial proteomics and image analytics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 790.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-790
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 790: Cellular decomposition and metabolic profiling of the tumor microenvironment tumor-stroma interface using high-dimensional spatial proteomics and image analytics.

Katherine Hales, Felicia M. Roland, Ritu Mihani, Michelle Poulin et al.
Cancer Research
Cancer Research and Treatments
article

Abstract 790: Cellular decomposition and metabolic profiling of the tumor microenvironment tumor-stroma interface using high-dimensional spatial proteomics and image analytics.

Katherine Hales, Felicia M. Roland, Ritu Mihani, Michelle Poulin, Arutha Kulasinghe, Daniel Winkowski
article en

Abstract

Abstract Introduction There is an urgent need for the development of better prognostic and predictive biomarkers for cancer immunotherapy across a number of solid cancers. Here we sought to characterise the tumour microevironment (TME) using high-dimensional spatial proteomics paired with advance image analytics to define tumour, stomal and interface regions. We developed custom functional and metabolic content to profile these interface regions to determine activity across transitional zones. Methods Using high dimensional spatial proteomic profiling (Phenocycler Fusion, Quanterix) with a custom immuno-metabolic panel targeting over 68 proteins, including markers for tumor, stroma, structural components, immune cell types, functional states, and metabolic activity, we characterized cell types, sub-types and metabolic activity across the tumor-stromal interface regions. Custom image analytics, utilizing Visiopharm’s analytic pipeline and workflow, enabled precise identification and mapping of spatially distinct tumor and stromal interface regions associated with TME composition. Characterization of cellularity and metabolic activity was further performed through the Phenoplex™ guided workflow. Results We found intra-tumor and intra-stromal regions were distinct from tumor-interface and stromal-interface regions in terms of TME composition and metabolic activity. Moreover, whilst cell proportions alone were not predictive of clinical benefit, the nuances were in the tumor and immune cell sub-types which were functionally and metabolically characterized. We found a tumor metabolic signature predictive of poorer clinical outcomes and reciprocally high metabolic activity in immune cells at the TME interface associated with benefit from immunotherapy. Conclusion Taken together, this study highlights the value of high-dimensional spatial proteomics covering functional and metabolic profiling of the TME and the advanced image analytics providing insights into the TME. Citation Format: Arutha Kulasinghe, Felicia Roland, Michelle Poulin, Ritu Mihani, Katherine Hales, Daniel Winkowski. Cellular decomposition and metabolic profiling of the tumor microenvironment tumor-stroma interface using high-dimensional spatial proteomics and image analytics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 790.

Cancer ResearchVol. 86(7_Supplement)
The University of Queensland (AU), Broomfield Hospital (GB), IQuum (United States) (US), Gabba Dermatology (AU)
No poverty
Openalex Percentile: Top 31%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.